STAT+: Definium’s LSD therapy eased anxiety in second large trial
Definium Therapeutics said Monday that its LSD therapy helped patients with anxiety in a second late-stage trial, setting up the company to seek the first approval of a psychedelic drug for anxiety. In the 12-week trial, patients taking a…
ImpactNotable 33/100
Why it mattersRule-based estimate: no strong signals; trust 8/10.
Regions🌐 Global
Published19 h ago (Mon, 14 Sep 2026 11:00:00 GMT)
RetrievedMon, 14 Sep 2026 17:39:54 GMT via rss
ClassifiedMon, 14 Sep 2026 17:40:00 GMT by heuristic
AuthorElaine Chen